A SLC1A3 variant associated with hemiplegic migraine and acetazolamide-responsive MRS changes
Data files
Dec 16, 2020 version files 246.88 KB
-
Figure_e-1.pdf
35.58 KB
-
Figure_e-2.pdf
38.28 KB
-
Supplementary_document_SLC1A3_.pdf
93.30 KB
-
Table_e-1_Clinical_features.pdf
40.76 KB
-
Table_e-2.pdf
38.96 KB
Abstract
Familial hemiplegic migraine (FHM) is a group of rare familial disorders caused, in most cases, by mutations in CACNA1A and ATP1A2.1 Heterozygous mutations in solute carrier family 1 member 3 (SLC1A3), encoding glial glutamate transporter, are associated with episodic ataxia type 6 (EA6).2,–5 In addition to episodic ataxia (EA), alternating hemiplegia and hemiplegic migraine have been reported twice in patients with EA6.2,4 Mutations in SLC1A3 are very rare; screenings in cohorts of EA and alternating hemiplegia have yielded either negative results3,6,–8 or variants of unclear significance.e-1--e-3 Herein, we characterize a patient featuring sporadic hemiplegic migraine (SHM) responsive to acetazolamide (ACZ) and mild cerebellar atrophy associated with a new variant in SLC1A3. We also report the utility of proton magnetic resonance spectroscopy (MRS) for this condition.